HC Wainwright Issues Pessimistic Outlook for DAWN Earnings
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Free Report) – Analysts at HC Wainwright decreased their Q2 2025 earnings per share estimates for shares of Day One Biopharmaceuticals in a report issued on Wednesday, May 7th. HC Wainwright analyst A. Maldonado now expects that the company will post earnings of ($0.32) per share for the quarter, […]
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Free Report) – Analysts at HC Wainwright decreased their Q2 2025 earnings per share estimates for shares of Day One Biopharmaceuticals in a report issued on Wednesday, May 7th. HC Wainwright analyst A. Maldonado now expects that the company will post earnings of ($0.32) per share for the quarter, […]
